Download Citation
Article Source:
Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States
Fisher SS,
Lindaas A,
Muthuri SG,
Lloyd PC,
Gruber JF,
et al.
(2025)
Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United States.
PLOS ONE 20(11): e0333704.
https://doi.org/10.1371/journal.pone.0333704